Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

UDoTest

UDoTest?uq=AFYHfsyn
2012 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$350K LATEST DEAL AMOUNT
1 INVESTORS
Description

Provider of self-sampling screening test kits intended to conduct colon cancer and other wellness tests for early detection of diseases. The company's self-screening testing products permits conducting of accurate pathology tests to detect diseases such as HPV, STD, Colon and Gluten Intolerance, enabling patients to verify their state of health right at their homes in a comfortable, affordable and simple manner.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Drug Delivery
Primary Office
  • 15 Eastwood Road
  • Dunkeld
  • Johannesburg, Gauteng 2196
  • South Africa

+27 011 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore UDoTest’s full profile, request a free trial.

UDoTest Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2017 $350K 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

UDoTest Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Launchpad Digital Health Accelerator/Incubator Minority 000 0000 000000 0

UDoTest Executive Team (1)

Name Title Board
Seat
Contact
Info
Allison Martin Founder, Chief Executive Officer & Managing Director